This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Supplementary information
Supplementary information S1 (box)
Dataset and analysis methods (PDF 322 kb)
PowerPoint slides
Rights and permissions
About this article
Cite this article
Fiala, J., Lowery, D. Migraine therapies targeting the CGRP pathway: intellectual property landscape. Nat Rev Drug Discov 15, 8–9 (2016). https://doi.org/10.1038/nrd.2015.11
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrd.2015.11
This article is cited by
-
Erenumab — Empfehlungen für die Praxis
Schmerzmedizin (2019)
-
Evidence of insufficient quality of reporting in patent landscapes in the life sciences
Nature Biotechnology (2017)